Amneal Pharmaceuticals Inc Ordinary Shares - Class A AMRX
News
Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers
Amneal Reports Third Quarter 2026 Financial Results
Amneal to Report Third Quarter 2026 Results on November 3, 2026
Ipsen Shares Fall After Early Launch of U.S. Generic Rival
Stocks to Watch: Paramount Skydance, Warner Bros. Discovery, Accenture, Amneal Pharmaceuticals
Amneal Gets FDA Approval for Generic Hormone Drug
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Amneal, mAbxience Get FDA Approval For Two Biosimilars
FDA Clears Amneal Epinephrine Injection
Amneal Gets Tentative FDA Approval for Asthma Treatment

